Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
In a review published last year, Sikiric and his colleagues describe BPC-157 as a drug like no other: In animal models, it counteracts symptoms akin to those of Parkinsons, Alzheimers, and schizophrenia
Safety and efficacy in pediatric populations have not been established
The peptide is metabolized by standard peptidase activity but shows unusual resistance to gastric acid degradation, with stability documented in pH as low as 1.5 for over 24 hours
Markets (2020): ~807 in trials
US$ 29.46
US$ 23.52
US$ 21.27
US$ 28.91
US$ 29.92
US$ 23.35
US$ 26.02
US$ 29.86
